28 related articles for article (PubMed ID: 6937651)
1. Preparation of magnetic polybutylcyanoacrylate nanospheres encapsulated with aclacinomycin A and its effect on gastric tumor.
Gao H; Wang JY; Shen XZ; Deng YH; Zhang W
World J Gastroenterol; 2004 Jul; 10(14):2010-3. PubMed ID: 15237424
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activity of ME2303, a fluorine-containing anthracycline, against human tumors implanted in nude mice.
Tsuruo T; Sato S; Yusa K
Jpn J Cancer Res; 1989 Jul; 80(7):686-9. PubMed ID: 2507492
[TBL] [Abstract][Full Text] [Related]
3. [Experimental study of the antitumor anthracycline antibiotic aclarubicin (aclacinomycin A)].
Egorov LV; Terent'eva TG; Rudneva NA; Egorenko GG; Ivanitskaia LP
Antibiot Med Biotekhnol; 1985 Dec; 30(12):918-27. PubMed ID: 3866512
[TBL] [Abstract][Full Text] [Related]
4. Potentiation of adriamycin accumulation and effectiveness in adriamycin-resistant cells by aclacinomycin A.
Tapiero H; Boulé D; Trincal G; Fourcade A; Lampidis TJ
Leuk Res; 1988; 12(5):411-8. PubMed ID: 3164087
[TBL] [Abstract][Full Text] [Related]
5. MX2, a morpholino anthracycline, as a new antitumor agent against drug-sensitive and multidrug-resistant human and murine tumor cells.
Watanabe M; Komeshima N; Nakajima S; Tsuruo T
Cancer Res; 1988 Dec; 48(23):6653-7. PubMed ID: 3180075
[TBL] [Abstract][Full Text] [Related]
6. Phase I and pharmacokinetic study of high volume intraperitoneal aclacinomycin-A (Aclarubicin).
Kerr IG; Archer S; DeAngelis C; Farrell S; Hanna S; McKee J
Invest New Drugs; 1987; 5(2):171-6. PubMed ID: 3477533
[TBL] [Abstract][Full Text] [Related]
7. [Intravesical instillation therapy of aclacinomycin-A (ACM) for superficial bladder tumor].
Noguchi S; Kubota Y; Shuin T; Miura T; Moriyama M; Sakuramoto T; Oshima H
Hinyokika Kiyo; 1984 Sep; 30(9):1153-8. PubMed ID: 6596878
[TBL] [Abstract][Full Text] [Related]
8. Antitumor efficacies of aclacinomycin A by oral administration.
Tsukagoshi S; Tsuruo T; Yamori T; Iida H; Naganuma K; Sakurai Y
J Pharmacobiodyn; 1980 Oct; 3(10):532-6. PubMed ID: 6937651
[TBL] [Abstract][Full Text] [Related]
9. Experimental studies on aclacinomycin.
Tone H; Nishida H; Takeuchi T; Umezawa H
Drugs Exp Clin Res; 1985; 11(1):9-15. PubMed ID: 2424701
[TBL] [Abstract][Full Text] [Related]
10. [Study of new antineoplastic antibiotics based on newly discovered action mechanisms].
Tanaka N
Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1094-106. PubMed ID: 6191673
[TBL] [Abstract][Full Text] [Related]
11. Aclacinomycin A: clinical development of a novel anthracycline antibiotic in the haematological cancers.
Warrell RP
Drugs Exp Clin Res; 1986; 12(1-3):275-82. PubMed ID: 3525076
[TBL] [Abstract][Full Text] [Related]
12. [Aclacinomycin A: a new antitumor antibiotic].
Egorov LV; Ivanitskaia LP; Navashin SM
Antibiotiki; 1982; 27(7):540-55. PubMed ID: 6753735
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]